Introduction {#sec1}
============

A domino reaction design has received attention in synthetic organic chemistry because it provides reliable, efficient, and environmentally friendly alternatives from readily available starting materials.^[@ref1]−[@ref5]^ The development of a new domino reaction sequence can be considered a significant intellectual challenge, which does not bring only practical efficiency but also an aesthetic appeal in the human mind.^[@ref6]−[@ref8]^ Therefore, it has been emerged as a mainstream in synthetic organic chemistry. Due to the mild conditions and compatibility for common functionalities, the Rh-catalyzed hydroformylation^[@ref9]−[@ref11]^ appears to be a useful tool in synthetic organic chemistry.^[@ref12]−[@ref18]^ As part of our interest in domino reaction, here we describe a novel one-pot Rh-catalyzed domino hydroformylation double cyclization for rapid construction azabicyclo heterocycles.

The design is outlined in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}: Rh-catalyzed hydroformylation of the monosubstituted alkene **1** produces desired linear aldehyde **2**, which can trigger a series of intramolecular transformations spontaneously ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Aldehyde **2** undergoes the first condensation with the amide moiety to give aminal **3**. Subsequent dehydration occurs to yield N-acyliminium **4**. Different from our previous strategy,^[@ref19],[@ref20]^ the present design takes advantage of a trisubstituted alkene as the π nucleophile^[@ref21]^ to proceed the intramolecular Mannich cyclization to form a stable tertiary carbocationic bicyclized product **5**. Releasing a proton in an E1 manner yields *gem*-disubstituted alkene **6** rather than a tetrasubstituted alkene, probably due to significant A^1,3^-strain in the latter situation. The resulting alkene **6** will not undergo further hydroformylation because it requires a higher pressure and forced conditions.

![Rh-Catalyzed Domino Hydroformylation Double Cyclization of Trisubstituted Alkenes, Illustrated by the Example of Allylamide Substrate **1a**](ao9b04400_0005){#sch1}

Compared to the nucleophilic arylacetylene group, the trisubstituted alkene group provides more diversity in the flowing chemical transformations. Moreover, the resulting isopropenyl group is able to provide more diversity in the following chemical transformations. Therefore, we design three kinds of amide substrates: allyl amides (**1a**, **1d**, and **1g)**, butenamides (**1b**, **1e**, and **1h)**, and homoallylamides (**1c**, **1f**, and **1i**), to investigate the scope and limitation of the idea ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Design substrates for the double reaction.](ao9b04400_0007){#fig1}

Results and Discussion {#sec2}
======================

These amides are readily prepared from the corresponding acids and amines by means of a standard carbodiimide coupling or a chloroformate activation protocol. At first, allylamide **1a** was chosen as the model system to find the conditions and subjected to the previously developed conditions, that is, the use of 10 mol % PTSA at 60 °C, 4 atm of CO/H~2~ (1:1), and 0.05 M substrate concentration. The results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Pleasingly, we were able to isolate the desired product **6a** albeit in 14% yield as a 1.4:1 inseparable *cis*/*trans* mixtures^[@ref22]^ and monocyclized product aminal **3a** in 20% (entry 1). The treatment of aminal **3a** in with BF~3~·OEt~2~ in dichloromethane afforded the cyclized product **6a** in 66% yield ([eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}).

###### Optimizations on Hydroformylation Double Cyclization Conditions for Alkene **1a**

![](ao9b04400_0003){#gr7}

  entry[a](#t1fn1){ref-type="table-fn"}   PTSA        **3a** (%)   **6a** (%)[b](#t1fn2){ref-type="table-fn"}^,^[c](#t1fn3){ref-type="table-fn"}
  --------------------------------------- ----------- ------------ -------------------------------------------------------------------------------
  1                                       10 mol %    42           14
  2                                       50 mol %    20           28
  3                                       1.0 equiv   ND           66
  4                                       1.5 equiv   ND           44
  5                                       2.0 equiv   ND           45
  6                                       3.0 equiv   ND           40
  7[d](#t1fn4){ref-type="table-fn"}       1.0 equiv   ND           82

All reactions were run with 1.0 mmol of **1a** (0.05 M in 20 mL of solvent), for 16--20 h.

Isolated yield.

The *cis*/*trans* ratio was about 1.4 in all entries.

Without aqueous workup.

ND: not detected.

It suggested that the amount of acid might be a crucial role in the reaction. Thus, we attempted to increase the amount of the acid to improve the yield. Addition of 50 mol % PTSA in the reaction improved the cyclized product in 28% yield, as well as **3a** in 20% yield (entry 2). The addition within 1 equiv of pTSA afford the desired product **6a** in 66% isolated yield (entry 3). However, more amount of pTSA did not bring significant improvement in the yield of product **6a** but resulted in disappearance of product **3a** (entries 4--6). It was noteworthy to point out that the resulting germinal alkene moiety did not undergo further hydroformylation as we anticipated. In addition, we found that the monocyclized product **3a** would suffer weight loss during purification, probably due to decomposition in silica gel or in acidic conditions for a long time. Thus, direct treatment of the crude residue with BF~3~·OEt~2~ in dichloromethane after evaporation to remove acetic acid brought satisfiying results. Such an operation rendered complete formation of bicyclized product **6a** in 82% isolated yield (entry 7).

Once the optimized conditions were in hand, we were able to study the scope and limitation of the reaction using various amide substrates ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The reaction of 3-butenamide **1b** under the optimized conditions afforded only one diastereomer, *trans* 4-oxoquinolizidine **6b** in 75% yield, while the reaction of the other isomer homoallylamide **1c** afforded both *cis-* and *trans*-6-oxoquinolizidine **6c** in 63% yield as inseparable mixtures (1.5:1). In addition, in the investigation on 6-methyl-5-heptenamide substrates (**1d** and **1f**, *m* = 2), only the reaction of allylamide **1d** could afford pyrrolidine-fused azepane **6d** as a single *trans* product in a good yield of 78%, while the reactions of the butenamide **1e** and the homoallylamide **1f** could not provide the cyclized products. The reactions of allylamide **1g** and homoallylamide **1i** did not give the anticipated bicyclized product **6**, but the reaction of butenamide **1h** could produce the desired product only in 27% yield as a 2.5:1 inseparable mixture of *cis*/*trans* isomers.

![Results of hydroformylation double cyclization.](ao9b04400_0006){#fig2}

To extend the following functional group transformation, our attention next turns to examining a protocol for utilization of the isopropenyl group ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The exposure of indolizidine **6a** in the ozonolysis conditions gave only a decomposed result (entry 1). The treatment with OsO~4~--oxone in DMF failed to produce methylketone product (entry 2).^[@ref23]^ However, Upjohn dihydroxylation, that is, a catalytic amount of OsO~4~ and a stoichiometric amount of NMO followed by NaIO~4~ cleavage of the resulting diol afforded 31% of *cis*-ketone **7a** and 27% of *trans*-ketone **7a** (entry 3). A better result was achieved by employing the Nicolaou's protocol.^[@ref24]^ Treatment with NMO and 2,6-lutidine in the presence of a catalytic amount OsO~4~ in acetone/water followed by addition of DAIB (diacetoxyiodobenzene) produced 44% of *cis*-ketone **7a** and 37% of *trans*-ketone **7a** (entry 4).

###### Optimizations on Oxidative Cleavage of Alkene **6a**

![](ao9b04400_0002){#gr8}

  entry                      reagent 1            solvent         *T* (°C)   reagent 2             *cis*-**7a** (%)[a](#t2fn1){ref-type="table-fn"}   *trans-***7a** (%)
  -------------------------- -------------------- --------------- ---------- --------------------- -------------------------------------------------- --------------------
  1                          O~3~                 CH~2~Cl~2~      --78       Me~2~S (1.4 equiv)    ND                                                 ND
  2                          OsO~4~ (1.0 mol %)   DMF             rt                               ND                                                 ND
  oxone (4.0 equiv)                                                                                                                                   
  3                          OsO~4~ (3.3 mol %)   acetone         rt         NaIO~4~ (2.0 equiv)   31                                                 27
  NMO (1.0 equiv)                                                                                                                                     
  4                          OsO~4~ (3.3 mol %)   acetone/H~2~O   40         DAIB (1.5 equiv)      44                                                 37
  NMO (1.0 equiv)                                                                                                                                     
  2,6-lutidine (2.0 equiv)                                                                                                                            

Isolated yield.

After being treated with DBU in dichloromethane at room temperature overnight, *cis*-ketone **7a** was transformed completely to the *trans* isomer **7a**. The results indicated *trans*-ketone **7a** was thermodynamically stable product. The condensation of *trans* ketone **7a** with tosylhydrazine in refluxing methanol resulted in the formation of tosylhydrazone derivative *trans*-**8a** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The precipitate could be recrystallized from the solution to give single crystals (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04400/suppl_file/ao9b04400_si_001.pdf), CCDC no. 1920287) for the X-ray diffraction analysis. It apparently possesses a *trans* configuration between two methines, that is, C-8 and C-8a.

![Epimerization of *cis*-Ketone **7a** to *trans* Isomer and Tosylhydrazone Derivative **8a** and ORTEP Structure of **8a**](ao9b04400_0008){#sch2}

To demonstrate the methodology, we develop a series of simple operations for synthesis of *Dendrobatid* alkaloid epi-epiquinamide ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).^[@ref25]−[@ref32]^ Following the optimized oxidative cleavage conditions, *trans* quinolizidine **6b** was transformed to *trans*-ketone **7b** in 88% yield. Reduction with LiAlH~4~ to reduce two carbonyl groups afforded a diastereomeric mixture of quinolizidine alcohol **9b** in 74% yield. Exposure of alcohol **9b** with Dess--Martin periodinane afforded the methylketone **10b** in 89% yield, in which the tertiary amine remained intact during oxidation. The methylketone **10b** was subjected to condensation with hydroxylamine to afford oxime **11b**, which would be converted to an amide group through Beckmann rearrangement. Thus, the resulting oxime **11b** was treated with PCl~5~ in dichloromethane to produce amide **12** in 20% yield as a 1:1 mixture of *cis*/*trans* isomers, while with TFA to obtain methylketone **10b** in 38% yield. The reaction of oxime **11b** with sulfonyl chloride such as TsCl and MsCl gave the sulfonates as a leaving group,^[@ref33]^ which should enhance the nucelofugality^[@ref34],[@ref35]^ and improve the response. However, subsequent treatment with triethylamine led either to recovery of the starting materials or to complete destruction if in forcing conditions. Treatment of oxime **11b** with cyanuric chloride in DMF at an elevated temperature^[@ref36]^ afforded the arranged product as a 1:3 mixture^[@ref37]^ of the *cis* (epiquinamide) to *trans* (epi-epiquinamide) amide **12** in a combined yield of 64%. The spectra data were identical to those reported.^[@ref32]^

![Syntheses of Epiquinamide](ao9b04400_0004){#sch3}

In summary, we have reported a novel reaction, trisubstituted alkene-mediated domino hydroformylation/double cyclization, to synthesize indolizidine, quinolizidine, and pyrrolidine-fused azepane skeleton from simple amide derivatives. Subsequent elaboration of the bicyclic product **6** into ketone **7** was effected by the optimized cleavage conditions and furnished a *Dendrobatid* alkaloid *epi*-epiquinamide in six steps. The methodology provides rapid construction of azabicyclo\[4.4.0\]decane and azabicyclo\[5.3.0\]decane systems based on the excellent diastereoselectivity. Further applications of other natural products are under investigation and will be reported in due course.

Experimental Section {#sec3}
====================

The reactions were performed under an argon atmosphere and in an anhydrous solvent, unless otherwise stated. The solvents and reagents were dried or refined according to the literature procedures. The crude products were purified by flash column chromatography on silica gel to give isolated yields. All NMR spectra, for example, ^1^H, ^13^C, DEPT, gCOSY, gHSQC, and gHMBC, were recorded on a 400 MHz or a 600 MHz NMR spectrometer, which provided all necessary data for the full assignment of each compound. Chemical shifts (δ) are reported in ppm using residual undeuterated solvent as an internal standard. Coupling constants are described in Hertz. The X-ray crystal results have been checked to obtain the corresponding CCDC number. Mass spectra were recorded on a mass spectrometer with a magnetic sector using the electrospray ionization (ESI) or fast atom bombardment (FAB).

General Procedure for the Preparation of Amide Substrates **1a**--**1i**^[@ref38],[@ref39]^ {#sec3.1}
-------------------------------------------------------------------------------------------

### Method A {#sec3.1.1}

To a solution of the corresponding acid (10.0 mmol, 1.0 equiv) in THF was added triethylamine (1.47 mL, 10.5 mmol, 1.05 equiv) at room temperature under an atmosphere of nitrogen followed by addition of methyl chloroformate (0.81 mL, 10.5 mmol, 1.05 equiv). After 20 min, the corresponding amine (1.05 equiv) was added. The reaction mixture was allowed to be stirred overnight (∼21 h) under nitrogen. On completion of the reaction, the solvent was removed in vacuo, and the reaction mixture was partitioned with diethyl ether (20 mL) and water (30 mL). The aqueous solution was extracted with diethyl ether (20 mL ×3) again. The combined organic layers were washed with brine (50 mL), dried over anhydrous Na~2~SO~4~, and then concentrated under reduced pressure to give a crude product. Purification of the crude product by flash chromatography on silica gel using EtOAc/*n*-hexane as the eluant afforded the corresponding amide in a high yield.

### Method B {#sec3.1.2}

To a mixture of the corresponding acid (10.0 mmol, 1.0 equiv), EDC (1.917 g, 10.0 mmol, 1.1 equiv), and HOBt (1.836 g, 12.0 mmol, 1.3 equiv) in CH~2~Cl~2~ (5.0 mL) in an ice bath was added the corresponding amine (10.0 mmol, 1.0 equiv) via a syringe. The reaction mixture was allowed to stir overnight (∼21 h) under nitrogen. The reaction mixture was partitioned with CH~2~Cl~2~ (20 mL) and saturated NaHCO~3~ solution (10 mL). The organic layer was washed with saturated NH~4~Cl solution (10 mL). The aqueous solution was extracted with CH~2~Cl~2~ (20 mL ×2) again. The combined organic layers were washed with brine (10 mL), dried over anhydrous Na~2~SO~4~, and then concentrated under reduced pressure to give a crude product. Purification of the crude product by flash chromatography on silica gel using EtOAc/*n*-hexane as the eluant afforded the corresponding amide in a high yield.

#### *N*-Allyl-5-methyl-4-hexenamide (**1a**) {#sec3.1.2.1}

Method A; 85% yield; light yellow oil; *R~f~* = 0.12 (EtOAc/*n*-Hex = 1:3); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.57 (s, 3H, H-6′), 1.63 (s, 3H, H-6), 2.16--2.20 (m, 2H, H-2), 2.27 (q, *J* = 7.2 Hz, 2H, H-3), 3.81 (q, *J* = 6.0 Hz, 2H, −NH--C[H]{.ul}~[2]{.ul}~), 5.08--5.14 (m, 3H, H-4 and ---CH=C[H]{.ul}~[2]{.ul}~), 5.73--5.82 (m, 1H, ---C[H]{.ul}=CH~2~), 6.05 (brs, 1H, −N[H]{.ul}--CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.6 (q, C-6′), 24.2 (t, C-2), 25.5 (q, C-6), 36.5 (t, C-3), 41.7 (t, −NH--[C]{.ul}H~2~), 115.9 (t, ---CH=[C]{.ul}H~2~), 112.7 (d, C-4), 132.9 (s, C-5), 134.2 (d, ---[C]{.ul}H=CH~2~), 172.7 (s, C-1); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~10~H~17~NO^+^, 167.1310; found, 167.1309 (Δ = 0.6 ppm).

#### *N*-(5-Methyl-4-hexen-1-yl)-3-butenamide (**1b**) {#sec3.1.2.2}

Method B; 77% yield; light yellow oil; *R~f~* = 0.21 (EtOAc/*n*-Hex = 1:1); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.52 (quint, *J* = 7.2 Hz, 2H, H-2), 1.58 (s, 3H, H-6′), 1.67 (s, 3H, H-6), 2.00 (q, *J* = 7.2 Hz, 2H, H-3), 2.98 (d, *J* = 7.2 Hz, 2H, −COC[H]{.ul}~[2]{.ul}~), 3.23 (q, *J* = 7.2 Hz, 2H, H-1), 5.06--5.10 (m, 1H, H-4), 5.18--5.24 (m, 2H, ---CH=C[H]{.ul}~[2]{.ul}~), 5.66 (brs, 1H, −N[H]{.ul}--CH~2~), 5.86--5.96 (m, 1H, ---C[H]{.ul}=CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.5 (q, C-6′), 25.3 (t, C-2), 25.5 (q, C-6), 29.4 (t, C-3), 39.2 (t, −COC[H]{.ul}~[2]{.ul}~), 41.5 (t, C-1), 119.2 (t, ---CH=C[H]{.ul}~[2]{.ul}~), 123.3 (d, C-4), 131.5 (s, C-5), 132.1 (d, ---[C]{.ul}H=CH~2~), 170.4 (s, −[C]{.ul}ONH−); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~19~NO^+^, 181.1467; found, 181.1475 (Δ = 4.4 ppm).

#### *N*-(3-Buten-1-yl)-5-methyl-4-hexenamide (**1c**) {#sec3.1.2.3}

Method A; 81% yield; light yellow oil; *R~f~* = 0.18 (EtOAc/*n*-Hex = 1:3); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.57 (s, 3H, H-6′), 1.63 (s, 3H, H-6), 2.12--2.28 (m, 6H, H-2 and H-3 and ---C[H]{.ul}~[2]{.ul}~CH=CH~2~), 3.26 (q, *J* = 6.4 Hz, 2H, −NH--C[H]{.ul}~[2]{.ul}~), 5.01--5.06 (m, 3H, H-4 and ---CH=C[H]{.ul}~[2]{.ul}~), 5.66--5.76 (m, 1H, ---C[H]{.ul}=CH~2~), 5.85 (brs, 1H, −N[H]{.ul}--CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.6 (q, C-6′), 24.2 (t, C-3), 25.5 (q, C-6), 33.6 (t, C-2), 36.6 (t, ---[C]{.ul}H~2~CH=CH~2~), 38.3 (t, −NH--[C]{.ul}H~2~), 116.9 (t, ---CH=[C]{.ul}H~2~), 122.7 (d, C-4), 132.9 (s, C-5), 135.2 (d, ---[C]{.ul}H=CH~2~), 172.7 (s, C-1); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~19~NO^+^, 181.1467; found, 181.1470 (Δ = 1.7 ppm).

#### *N*-Allyl-6-methyl-5-heptenamide (**1d**) {#sec3.1.2.4}

Method A; 97% yield; light yellow oil; *R~f~* = 0.23 (EtOAc/*n*-Hex = 1:2); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.57 (s, 3H, H-7′), 1.64--1.71 (m, 5H, H-7 and H-3), 2.00 (q, *J* = 6.8 Hz, 2H, H-4), 2.17 (t, *J* = 7.2 Hz, 2H, H-2), 3.84--3.87 (m, 2H, −NH--C[H]{.ul}~[2]{.ul}~), 5.06--5.18 (m, 3H, H-5 and ---CH=C[H]{.ul}~[2]{.ul}~), 5.17 (brs, 1H, −N[H]{.ul}--CH~2~), 5.76--5.85 (m, 1H, ---C[H]{.ul}=CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.7 (q, C-7′), 25.6 (q, C-7), 25.8 (t, C-3), 27.4 (t, C-4), 36.1 (t, C-2), 41.8 (t, −NH--C[H]{.ul}~[2]{.ul}~), 116.2 (t, ---CH=[C]{.ul}H~2~), 123.5 (d, C-5), 132.5 (s, C-6), 134.3 (d, ---[C]{.ul}H=CH~2~), 172.9 (s, C-1); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~19~NO^+^, 181.1467; found, 181.1473 (Δ = 3.3 ppm).

#### *N*-(6-Methyl-5-hepten-1-yl)-3-butenamide (**1e**) {#sec3.1.2.5}

Method B; 78% yield; light yellow oil; *R~f~* = 0.27 (EtOAc/*n*-Hex = 1:2); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.31 (quint, *J* = 7.6 Hz, 2H, H-3), 1.47 (quint, *J* = 7.2 Hz, 2H, H-2), 1.56 (s, 3H, H-7′), 1.65 (s, 3H, H-7), 1.96 (q, *J* = 7.2 Hz, 2H, H-4), 2.97 (d, *J* = 7.2 Hz, 2H, −COC[H]{.ul}~[2]{.ul}~), 3.21 (q, *J* = 7.2 Hz, 2H, H-1), 5.04--5.08 (m, 1H, H-5), 5.16--5.22 (m, 2H, ---CH=C[H]{.ul}~[2]{.ul}~), 5.75 (brs, 1H, −N[H]{.ul}--CH~2~), 5.85--5.96 (m, 1H, ---C[H]{.ul}=CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.6 (q, C-7′), 25.6 (q, C-7), 27.0 (t, C-3), 27.5 (t, C-2), 29.1 (t, C-4), 39.5 (t, −COC[H]{.ul}~[2]{.ul}~), 41.6 (t, C-1), 119.6 (t, ---CH=C[H]{.ul}~[2]{.ul}~), 124.1 (d, C-5), 131.5 (d, ---[C]{.ul}H=CH~2~), 131.8 (s, C-6), 170.4 (s, −[C]{.ul}ONH−); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~12~H~21~NO^+^, 195.1623; found, 195.1624 (Δ = 0.5 ppm).

#### *N*-(3-Buten-1-yl)-6-methyl-5-heptenamide (**1f**) {#sec3.1.2.6}

Method A; 95% yield; light yellow oil; *R~f~* = 0.33 (EtOAc/*n*-Hex = 1:2); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.58 (s, 3H, H-7′), 1.61--1.67 (m, 5H, H-7 and H-3), 2.00 (q, *J* = 7.2 Hz, 2H, H-4), 2.14 (t, *J* = 7.6 Hz, 2H, H-2), 2.25 (q, *J* = 6.8 Hz, 2H, ---C[H]{.ul}~[2]{.ul}~CH=CH~2~), 3.32 (q, *J* = 6.4 Hz, 2H, −NH--C[H]{.ul}~[2]{.ul}~), 5.06--5.11 (m, 3H, H-5 and ---CH=C[H]{.ul}~[2]{.ul}~), 5.54 (brs, 1H, −N[H]{.ul}--CH~2~), 5.70--5.78 (m, 1H, ---C[H]{.ul}=CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.7 (q, C-7′), 25.6 (q, C-7), 25.8 (t, C-3), 27.4 (t, C-4), 33.7 (t, C-2), 36.2 (t, ---[C]{.ul}H~2~CH=CH~2~), 38.3 (t, −NH--C[H]{.ul}~[2]{.ul}~), 117.2 (t, ---CH=C[H]{.ul}~[2]{.ul}~), 123.6 (d, C-5), 132.4 (s, C-6), 135.3 (d, ---[C]{.ul}H=CH~2~), 173.1 (s, C-1); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~12~H~21~NO^+^, 195.1623; found, 195.1632 (Δ = 4.6 ppm).

#### *N*-Allyl-4-methyl-3-pentenamide (**1g**) {#sec3.1.2.7}

Method B; 97% yield; light yellow oil; *R~f~* = 0.14 (EtOAc/*n*-Hex = 1:3); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.55 (s, 3H, H-5′), 1.66 (s, 3H, H-5), 2.87 (d, *J* = 7.2 Hz, 2H, H-2), 3.74--3.76 (m, 2H, −NH--C[H]{.ul}~[2]{.ul}~), 4.98--5.02 (m, 2H, ---CH=C[H]{.ul}~[2]{.ul}~), 5.19--5.23 (m, 1H, H-3), 5.66--5.77 (m, 1H, ---C[H]{.ul}=CH~2~), 6.28 (brs, 1H, −N[H]{.ul}--CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.6 (q, C-5′), 25.4 (q, C-5), 35.6 (t, C-2), 41.6 (t, −NH--[C]{.ul}H~2~), 115.6 (t, ---CH=[C]{.ul}H~2~), 116.6 (d, C-3), 134.1 (d, ---[C]{.ul}H=CH~2~), 134.2 (s, C-4), 171.3 (s, C-1); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~9~H~15~NO^+^, 153.1154; found, 153.1146 (Δ = 5.2 ppm).

#### *N*-(4-Methyl-3-penten-1-yl)-3-butenamide (**1h**) {#sec3.1.2.8}

Method B; 83% yield; yellow oil; *R~f~* = 0.37 (EtOAc/*n*-Hex = 1:1); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.52 (s, 3H, H-5′), 1.61 (s, 3H, H-5), 2.10 (q, *J* = 6.8 Hz, 2H, H-2), 2.90 (d, *J* = 6.8 Hz, 2H, ---C[H]{.ul}~[2]{.ul}~CH=CH~2~), 3.11--3.17 (m, 2H, H-1), 4.97--5.00 (m, 1H, H-3), 5.08--5.13 (m, 2H, ---CH=C[H]{.ul}~[2]{.ul}~), 5.78--5.89 (m, 1H, ---C[H]{.ul}=CH~2~), 6.16 (brs, 1H, −N[H]{.ul}--CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.6 (q, C-5′), 25.5 (q, C-5), 27.8 (t, C-2), 39.1 (t, ---[C]{.ul}H~2~CH=CH~2~), 41.4 (t, C-1), 119.1 (t, ---CH=[C]{.ul}H~2~), 120.5 (d, C-3), 131.4 (d, ---[C]{.ul}H=CH~2~), 134.1 (s, C-4), 170.4 (s, −[C]{.ul}ONH−); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~10~H~17~NO^+^, 167.1310; found, 167.1320 (Δ = 6.0 ppm).

#### *N*-(3-Buten-1-yl)-4-methyl-3-pentenamide (**1i**) {#sec3.1.2.9}

Method B; 80% yield; yellow oil; *R~f~* = 0.12 (EtOAc/*n*-Hex = 1:2); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.50 (s, 3H, H-5′), 1.63 (s, 3H, H-5), 2.11--2.12 (m, 2H, ---C[H]{.ul}~[2]{.ul}~CH=CH~2~), 2.81 (m, 2H, H-2), 3.15--3.18 (m, 2H, −NH--C[H]{.ul}~[2]{.ul}~), 4.91--4.95 (m, 2H, ---CH=C[H]{.ul}~[2]{.ul}~), 5.15--5.16 (m, 1H, H-3), 5.59--5.70 (m, 1H, ---C[H]{.ul}=CH~2~), 6.16 (brs, 1H, -N[H]{.ul}-CH~2~). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.5 (q, C-5′), 25.3 (q, C-5), 33.4 (t, ---[C]{.ul}H~2~CH=CH~2~), 35.6 (t, C-2), 38.0 (t, −NH--[C]{.ul}H~2~), 116.6 (t, ---CH=[C]{.ul}H~2~), 116.7 (d, C-3), 135.0 (d, ---[C]{.ul}H=CH~2~), 135.2 (s, C-4), 171.3 (s, C-1); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~10~H~17~NO^+^, 167.1310; found, 167.1313 (Δ = 1.8 ppm).

General Procedure for the Domino Double Cyclization {#sec3.2}
---------------------------------------------------

Rh(acac)(CO)~2~ (1.3 mg, 5.0 μmol, 0.5 mol %) and BIPHEPHOS (7.9 mg, 10 μmol, 1.0 mol %) were dissolved in AcOH (1 mL) under argon. The resulting catalyst solution was degassed by a frozen--thawed procedure at least three times. Amide (**1a**, 167 mg, 1.0 mmol, 1.0 equiv) and pTSA (17 mg, 0.1 mmol, 10 mol %) were placed in a 50 mL flask. The catalyst solution was transferred to the reaction flask containing the substrate by a pipette, and the total volume was adjusted to 20 mL with AcOH. The reaction flask was placed in a 300 mL stainless steel autoclave and then was pressurized with CO (2 atm) followed by H~2~ (2 atm). The reaction mixture was stirred at 60 °C for 16--20 h. Upon completion of the reaction, the gas was carefully released in a good ventilated hood, and the reaction mixture was concentrated under reduced pressure to give a crude residue. The residue was partitioned with CH~2~Cl~2~ (20 mL) and NaHCO~3~(aq) (saturated, 10 mL). After separation of the organic layer, the aqueous layer was extracted with CH~2~Cl~2~ (15 mL ×5). The combined organic layers were dried over anhydrous Na~2~SO~4~, filtered, and then concentrated under reduced pressure to give the crude product. The crude product was purified by flash chromatography on silica gel using MeOH/CH~2~Cl~2~ or EtOAc/*n*-hexane as the eluant to give the product.

### 8-(Propen-2-yl)-5-oxoindolizidine (**6a**) {#sec3.2.1}

82% yield (*cis*/*trans* = 3: 2); yellow oil; *R~f~* = 0.24 (MeOH/CH~2~Cl~2~ = 1:20); ^1^H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.34--1.39 (m, 1H, *trans* H-1), 1.71--1.81 (m, 12H, *trans* H-2 ×2, *cis* H-6 ×2, *trans* H-7 ×2, *cis* H-11 ×3, and *trans* H-11 ×3), 1.84--2.09 (m, 6H, *trans* H-1, *cis* H-2 ×2, *cis* H-7 ×2, and *trans* H-8), 2.31--2.43 (m, 3H, *cis* H-1 ×2 and *trans* H-6), 2.48--2.52 (m, 1H, *trans* H-6), 2.59 (q, *J* = 4.8 Hz, 1H, *cis* H-8), 3.33 (ddd, *J* = 4.8, 10.2, 10.2 Hz, 1H, *trans* H-8a), 3.44--3.60 (m, 4H, *cis* H-3 ×2 and *trans* H-3 ×2), 3.66 (ddd, *J* = 6.0, 6.0, 10.8, Hz, 1H, *cis* H-8a), 4.57--4.89 (m, 4H, *cis* H-10 ×2 and *trans* H-10 ×2). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 20.0 (q, *trans* C-11), 21.6 (t, *trans* C-2), 21.9 (t, *cis* C-2), 23.6 (q, *cis* C-11), 24.8 (t, *cis* C-7), 27.2 (t, *trans* C-7), 28.3 (t, *cis* C-6), 29.1 (t, *cis* C-1), 31.3 (t, *trans* C-6), 32.3 (t, *trans* C-1), 41.0 (d, *cis* C-8), 44.7 (t, *cis* C-3), 45.2 (t, *trans* C-3), 48.4 (d, *trans* C-8), 60.5 (d, *cis* C-8a), 61.8 (d, *trans* C-8a), 112.1 (t, *trans* C-10), 113.0 (t, *cis* C-10), 143.1 (s, *cis* C-9), 145.0 (s, *trans* C-9), 168.7 (s, *trans* C-5), 169.3 (s, *cis* C-5); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~17~NO^+^, 179.1310; found, 179.1315 (Δ = 2.9 ppm).

### *trans*-9-(Propen-2-yl)-4-oxoquinolizidine (**6b**) {#sec3.2.2}

75% yield; light yellow oil; *R~f~* = 0.31 (MeOH/CH~2~Cl~2~ = 1:30); ^1^H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.39--1.54 (m, 4H, H-1, H-2, H-7 and H-8), 1.63--1.71 (m, 6H, H-2, H-7, H-8 and H-12 ×3), 1.82--1.83 (m, 1H, H-1), 1.94 (t, *J* = 10.2 Hz, 1H, H-9), 2.22--2.27 (m, 1H, H-3), 2.32--2.36 (m, 2H, H-3 and H-6), 3.12--3.16 (m, 1H, H-9a), 4.72--4.77 (m, 3H, H-11 ×2 and H-6). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 18.5 (t, C-2), 19.1 (q, C-12), 24.9 (t, C-7), 27.1 (t, C-1), 30.8 (t, C-8), 32.8 (t, C-3), 42.5 (t, C-6), 51.6 (d, C-9), 58.8 (d, C-9a), 112.5 (t, C-11), 145.9 (s, C-10), 169.4 (s, C-4); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~12~H~19~NO^+^, 193.1467; found, 193.1469 (Δ = 1.0 ppm).

### 9-(Propen-2-yl)-6-oxoquinolizidine (**6c**) {#sec3.2.3}

63% yield (*cis*/*trans* = 3:2); yellow oil; *R~f~* = 0.27 (MeOH/CH~2~Cl~2~ = 1:30); 1H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.17--1.26 (m, 2H, *trans* H-1 and *cis* H-1), 1.32--1.51 (m, 6H, *cis* H-1, *trans* H-2, *trans* H-3 ×2, and *cis* H-8 ×2), 1.60--1.76 (m, 9H, *cis* H-2, *cis* H-3 ×2, *cis* H-12 ×3, and *trans* H-12 ×3), 1.80--1.95 (m, 5H, *trans* H-1, *cis* H-2, *trans* H-2 and *trans* H-8 ×2), 2.12--2.17 (m, 1H, *trans* H-9), 2.29--2.41 (m, 2H, *cis* H-4 and *trans* H-7), 2.43--2.52 (m, 5H, *trans* H-4, *cis* H-7 ×2, *trans* H-7 and *cis* H-9), 3.06 (ddd, *J* = 2.4, 11.4, 11.4 Hz, 1H, *trans* H-9a), 3.44 (dd, *J* = 5.4, 11.4 Hz, 1H, *cis* H-9a), 4.41--4.90 (m, 6H, *cis* H-4, *trans* H-4, *cis* H-11 ×2, and *trans* H-11 ×2). 13C NMR (100 MHz, 25 °C, CDCl~3~, δ): 19.6 (q, *trans* C-12), 21.2 (t, *cis* C-2), 22.3 (q, *cis* C-12), 24.2 (t, *trans* C-2), 24.9 (t, *cis* C-3), 25.05 (t, *trans* C-8), 25.13 (t, *cis* C-8), 25.5 (t, *trans* C-3), 26.8 (t, *cis* C-1), 32.0 (t, *trans* C-7), 32.3 (t, *cis* C-7), 32.5 (t, *trans* C-1), 42.4 (d, *cis* C-4), 43.4 (t, *cis* C-9), 44.6 (t, *trans* C-4), 49.1 (d, *trans* C-9), 59.0 (d, *cis* C-9a), 59.2 (d, *trans* C-9a), 111.8 (t, *cis* C-11), 112.9 (t, *trans* C-11), 144.0 (s, *cis* C-10), 145.0 (s, *trans* C-10), 168.1 (s, *cis* C-6), 168.8 (s, *trans* C-6); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~12~H~19~NO+, 193.1467; found, 193.1468 (Δ = 0.5 ppm).

### *trans*-9-(Propen-2-yl)-hexahydropyrrolo\[1,2-a\]azepin-5-one (**6d**) {#sec3.2.4}

78% yield; yellow oil; *R~f~* = 0.33 (MeOH/CH~2~Cl~2~ = 1:25); ^1^H NMR (600 MHz, 25 °C, C~6~D~6~, δ): 1.14--1.23 (m, 2H, H-1 and H-2), 1.24--1.31 (m, 2H, H-2 and H-7), 1.34 (s, 3H, H-12 ×3), 1.37--1.54 (m, 4H, H-1, H-7 and H-8 ×2), 1.68 (ddd, *J* = 3.0, 9.6, 12.0 Hz, 1H, H-9), 2.04 (t, *J* = 12.6 Hz, 1H, H-6), 2.57 (dd, *J* = 7.2, 13.8 Hz, 1H, H-6), 3.12 (q, *J* = 7.2 Hz, 1H, H-9a), 3.28 (ddd, *J* = 6.6, 6.6, 11.4 Hz, 1H, H-3), 3.73 (ddd, *J* = 6.0, 6.0, 12.0 Hz, 1H, H-3), 4.50--4.59 (m, 2H, H-11 ×2). ^13^C NMR (100 MHz, 25 °C, C~6~D~6~, δ): 19.2 (q, C-12), 22.9 (t, C-2), 23.3 (t, C-7), 32.1 (t, C-8), 36.4 (t, C-1), 37.9 (t, C-6), 47.1 (t, C-3), 52.7 (d, C-9), 60.1 (d, C-9a), 112.2 (t, C-11), 147.7 (s, C-10), 172.9 (s, C-5); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~12~H~19~NO^+^, 193.1467; found, 193.1460 (Δ = 3.6 ppm).

### 8-(Propen-2-yl)-4-oxoindolizidine (**6h**) {#sec3.2.5}

27% yield (*cis*/*trans* = 5:2); light yellow oil; *Rf* = 0.22 (MeOH/CH~2~Cl~2~ = 1:30); 1H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.09--1.16 (m, 1H, *trans* H-1), 1.22--1.29 (m, 1H, *cis* H-1), 1.60--1.73 (m, 7H, *trans* H-1, *cis* H-11 ×3, and *trans* H-11 ×3), 1.80--1.90 (m, 7H, *cis* H-1, *cis* H-2 ×2, *trans* H-2 ×2, and *cis* H-7 ×2), 1.96--2.03 (m, 2H, *trans* H-7 ×2), 2.14--2.25 (m, 2H, *cis* H-3 and *trans* H-8), 2.34--2.41 (m, 3H, *cis* H-3 and *trans* H-3 ×2), 2.79 (t, *J* = 6.6 Hz, 1H, *cis* H-8), 3.23 (ddd, *J* = 3.0, 10.2, 10.2 Hz, 1H, *trans* H-8a), 3.35--3.39 (m, 1H, *cis* H-6), 3.48 (q, *J* = 11.4, Hz, 1H, *trans* H-6), 3.52--3.57 (m, 2H, *trans* H-6 and H-8a) 3.72 (q, *J* = 9.0, Hz, 1H, *cis* H-6), 4.59--4.77 (m, 2H, *cis* H-10 ×2), 4.81 (s, 2H, *trans* H-10 ×2). 13C NMR (100 MHz, 25 °C, CDCl~3~, δ): 20.0 (q, *trans* t-11), 20.8 (2C, t, *cis* C-2 and *trans* C-2), 22.0 (q, *cis* C-11), 25.2 (t, *cis* C-1), 27.2 (t, *cis* C-7), 27.7 (t, *trans* C-7), 28.0 (t, *trans* C-1), 30.9 (2C, t, *cis* C-3 and *trans* C-3), 44.0 (t, *trans* C-6), 44.3 (d, *cis* C-6), 48.7 (t, *cis* C-8), 53.3 (d, *trans* C-8), 61.2 (d, *cis* C-8a), 61.4 (d, *trans* C-8a), 112.3 (t, *trans* C-10), 112.9 (t, *cis* C-10), 142.6 (s, *trans* C-9), 144.6 (s, *cis* C-9), 168.9 (s, *cis* C-4), 169.2 (s, *trans* C-4); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~17~NO+, 179.1310; found, 179.1311 (Δ = 0.6 ppm).

General Procedure of the Oxidative Cleavage {#sec3.3}
-------------------------------------------

To the mixed solution of acetone (16.5 mL) and water (1.5 mL) of the alkene substrate (**6a**, 323 mg, 1.80 mmol, 1.0 equiv) under argon was added 2,6-dimethylpyridine (0.42 mL, 3.60 mmol, 2.0 equiv), *N*-methylmorpholine oxide (50%, 0.6 mL, 2.70 mmol, 1.5 equiv), and OsO~4~ (2.3 mg, 0.009 mmol, 0.5 mol %). The solution was allowed to be stirred overnight (∼20 h) at 40 °C. The reaction was monitored by TLC in which the *R~f~* value of the starting material alkene is about 0.24 (MeOH/CH~2~Cl~2~ = 1:20), while the *R~f~* value of the product diol is about 0.10 in the same eluent. Upon completion of the reaction, PhI(OAc)~2~ (DAIB, 870 mg, 2.7 mmol, 1.5 equiv) was added and stirred overnight (∼20 h) at 60 °C. TLC analysis was used to follow the reaction. After evaporating the volatiles, the resulting reaction mixture was diluted with dichloromethane (20 mL) and washed with saturated Na~2~S~2~O~4~ solution (30 mL). The aqueous layer was extracted with dichloromethane (20 mL ×3). The organic layer was washed with brine (10 mL), dried over anhydrous Na~2~SO~4~, and then concentrated under reduced pressure to give a crude product. Purification of the crude product by flash chromatography on silica gel using ethyl acetate and *n*-hexane as the eluant gave the two titled products.

### *trans*-8-Acetyl-5-oxoindolizidine (*trans*-**7a**) {#sec3.3.1}

44% yield; yellow oil; *R~f~* = 0.37 (MeOH/CH~2~Cl~2~ = 1:20); ^1^H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.29--1.38 (m, 1H, H-1), 1.71--1.79 (m, 2H, H-2, and H-7), 1.90--1.98 (m, 1H, H-2), 2.08--2.12 (m, 1H, H-7), 2.15--2.18 (m, 1H, H-1), 2.22 (s, 3H, H-10 ×3), 2.35--2.46 (m, 2H, H-6 and H-8), 2.53 (dd, *J* = 6.6, 18.6 Hz, 1H, H-6), 3.44 (t, *J* = 10.2 Hz, 1H, H-3), 3.50--3.58 (m, 2H, H-3 and H-8a). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 22.0 (t, C-2), 24.9 (t, C-7), 29.4 (q, C-10), 30.7 (t, C-6), 32.0 (t, C-1), 44.7 (t, C-3), 53.1 (d, C-8), 59.5 (d, C-8a), 167.8 (s, C-5), 208.3 (s, C-9); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~10~H~15~NO~2~^+^, 181.1103; found, 181.1100 (Δ = 1.7 ppm).

### *cis*-8-Acetyl-5-oxoindolizidine (*cis-***7a**) {#sec3.3.2}

37% yield; yellow oil; *R~f~* = 0.33 (MeOH/CH~2~Cl~2~ = 1:20); ^1^H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.64--1.78 (m, 2H, H-1 and H-2), 1.85--2.01 (m, 3H, H-1, H-2, and H-7), 2.04--2.11 (m, 1H, H-7), 2.15 (s, 3H, H-10 ×3), 2.22--2.37 (m, 2H, H-6 ×2), 3.10 (q, *J* = 4.8, Hz, 1H, H-8), 3.41--3.44 (m, 1H, H-3), 3.49--3.54 (m, 1H, H-3), 3.59 (ddd, *J* = 5.4, 5.4, 10.2 Hz, 1H, H-8a). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 22.1 (t, C-2), 23.3 (t, C-7), 28.1 (t, C-6), 28.8 (t, C-1), 30.7 (q, C-10), 44.8 (t, C-3), 46.0 (d, C-8), 58.9 (d, C-8a), 168.2 (s, C-5), 207.9 (s, C-9); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~10~H~15~NO~2~^+^, 181.1103; found, 181.1104 (Δ = 0.6 ppm).

### *trans*-9-Acetyl-4-oxoquinolizidine (*trans*-**7b**)^[@ref40]^ {#sec3.3.3}

86% yield; yellow oil; *R~f~* = 0.33 (MeOH/CH~2~Cl~2~ = 1:25); ^1^H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.35--1.51 (m, 3H, H-1, H-7 and H-8), 1.59--1.67 (m, 1H, H-2), 1.73--1.79 (m, 2H, H-2 and H-7), 1.98--2.03 (m, 2H, H-1 and H-8), 2.18 (s, 3H, H-11 ×3), 2.26--2.32 (m, 1H, H-3), 2.37--2.42 (m, 2H, H-3 and H-6), 2.48 (ddd, *J* = 4.2, 11.4, 11.4 Hz, 1H, H-9), 3.50 (ddd, *J* = 6.0, 9.0, 9.0 Hz, 1H, H-9a), 4.80--4.83 (m, 1H, H-6). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 18.6 (t, C-2), 24.1 (t, C-7), 27.7 (t, C-1), 28.4 (t, C-8), 30.2 (q, C-11), 32.6 (t, C-3), 41.8 (t, C-6), 56.2 (d, C-9), 57.0 (d, C-9a), 169.4 (s, C-4), 210.0 (s, C-10); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~17~NO~2~^+^, 195.1259; found, 195.1263 (Δ = 2.0 ppm).

### *trans*-8-Acetyl-5-oxoindolizidine Tosylhydrazone (*trans*-**8a**, CCDC No. 1920287) {#sec3.3.4}

To the methanol solution (4 mL) of methylketone *trans*-**7a** (197 mg, 1.09 mmol, 1.0 equiv) under argon was added tosylhydrazide (223 mg, 1.19 mmol, 1.1 equiv). The solution was allowed to be stirred under reflux for 1 h. The reaction was monitored by TLC in which the *R~f~* value of the product is about 0.13 (pure EtOAc). Upon completion of the reaction, the reaction mixture was allowed to stand to cool slowly down to room temperature. A large quantity of white crystals separate during that time. The resulting white crystal was isolated by carefully washing with cold methanol and dried under vacuum for X-ray analysis (127 mg, 0.36 mmol, 33%): mp 236--238 °C; *R~f~* = 0.13 (pure EtOAc); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 1.07--1.26 (m, 1H), 1.49--1.71 (m, 2H), 1.71--1.80 (m, 1H), 1.82 (s, 3H), 1.92 (m, 1H), 2.02--2.20 (m, 1H), 2.20--2.41 (m, 2H), 2.43 (s, 3H), 2.46--2.61 (m, 1H), 3.46--3.38 (m, 2H), 3.48--3.68 (m, 1H), 7.32 (d, *J* = 8.0 Hz, 2H), 7.80 (d, *J* = 8.0 Hz, 2H), 8.02 (brs, 1H, NH); ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 15.3 (q), 21.6 (q), 22.0 (t), 26.1 (t), 31.0 (t), 31.9 (t), 45.2 (t), 48.7 (d), 60.6 (d), 128.0 (d), 129.4 (d), 135.3 (s), 144.1 (s), 156.2 (s), 168.4 (s).

### 1-(*trans*-Quinolizidin-1-yl)-1-ethanol (*trans*-**9b**) {#sec3.3.5}

To a reaction flask containing a mixture of LiAlH~4~ (858 mg, 22.6 mmol, 5.0 equiv) and triethylamine hydrochloride (3.11 g, 22.6 mmol, 5.0 equiv) in an ice bath was added THF (30 mL). The solution was allowed to be stirred for about 15 min in an ice bath until vigorous bubbling has ceased. To the reagent was added a THF solution (15 mL) of lactam *trans*-**7b** (883 mg 4.52 mmol, 1.0 equiv) via a cannula. The reaction mixture was allowed to be stirred at room temperature for 16 h. Upon the reaction completed, the reaction mixture was cooled in an ice bath, and then was quenched by slow addition of water (4.5 mL), aqueous sodium hydroxide solution (15%, 4.5 mL), and water (4.5 mL). White precipitates were filtered off by a short Celite pad. The resulting filtrate was concentrated under reduced pressure to give a crude product. Purification of the crude product by flash chromatography on *Chromatorex* N-H typed silica gel using ethyl acetate/*n*-hexane as the eluant afforded the titled product as a light yellow oil (614 mg, 3.35 mmol, 74%): *R~f~* = 0.37 (EtOAc/*n*-Hex = 1:1); ^1^H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.06--1.27 (m, 7H), 1.51--1.65 (m, 4H), 1.69--1.77 (m, 3H), 1.81--1.87 (m, 1H), 1.97--2.06 (m, 3H), 2.74--2.82 (m, 2H), 4.06--4.13 (m, 1H). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 17.0 (q), 21.2 (q), 22.3 (t), 22.6 (t), 24.5 (t), 24.6 (t), 24.8 (t), 24.9 (t), 25.2 (t), 25.4 (t), 29.0 (t), 29.1 (t), 47.1 (d), 47.7 (d), 56.4 (t), 56.6 (t), 56.8 (t), 57.0 (t), 63.9 (d), 64.7 (d), 66.2 (d), 66.5 (d); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~21~NO^+^, 183.1623; found, 183.1621 (Δ = 1.1 ppm).

### *trans*-9-Acetylquinolizidine (*trans*-**10b**) {#sec3.3.6}

To a CH~2~Cl~2~ solution (4 mL) of alcohol *trans*-**8b** (34 mg, 0.185 mmol, 1.0 equiv) in an ice bath under argon was added Dess--Martin reagent (86.5 mg, 0.204 mmol, 1.1 equiv) in three portions. The ice bath was removed, and the reaction mixture was allowed to be stirred at room temperature for 4 h. Upon completion of the reaction monitored by TLC analysis, the reaction was quenched with saturated NaHCO~3~ solution (15 mL). After filtration with a short Celite pad and separation of the organic layer, the aqueous layer was extracted with CH~2~Cl~2~ (10 mL ×4) again. The combined organic layers were washed with brine, dried over anhydrous Na~2~SO~4~, and then concentrated under reduced pressure to give a crude product. The crude product was purified by flash chromatography on *Chromatorex* N-H typed silica gel using ethyl acetate/*n*-hexane as the eluant afforded the titled product as a light yellow oil (29 mg, 0.16 mmol, 86%): *R~f~* = 0.37 (EtOAc/*n*-Hex = 1:5); ^1^H NMR (600 MHz, 25 °C, CDCl~3~, δ): 1.12--1.18 (m, 1H, H-1), 1.22--1.36 (m, 2H, H-2 and H-8), 1.53--1.61 (m, 3H, H-1 and H-3 ×2), 1.64--1.72 (m, 3H, H-2 and H-7 ×2), 1.83--1.87 (m, 1H, H-8), 2.00--2.08 (m, 3H, H-4, H-6 and H-9a), 2.14 (s, 3H, H-11), 2.44 (ddd, *J* = 3.6, 10.2, 13.2 Hz, 1H, H-9), 2.76--2.83 (m, 2H, H-4 and H-6). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 24.2 (t, C-2), 24.7 (t, C-7), 25.6 (t, C-3), 28.4 (t, C-8), 30.4 (q, C-11), 30.7 (t, C-1), 55.9 (t, C-6), 56.3 (d, C-9), 56.5 (t, C-4), 63.2 (d, C-9a), 211.6 (s, C-10); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~19~NO^+^, 181.1467; found, 181.1477 (Δ = 5.5 ppm).

### *Epi*-Epiquinamide (**12b**) {#sec3.3.7}

To a mixture of ketone *trans*-**10b** (179 mg, 0.987 mmol, 1.0 equiv) and hydroxylamine (0.36 mL, 5.92 mmol, 6.0 equiv) in in a 50 mL single-necked round-bottom flask was added benzene (14 mL) and EtOH (6 mL). The flask was equipped with a Dean-Stark trapper and a condenser, and the reaction mixture was allowed to be refluxed overnight (∼18 h) under argon to remove water. Upon completion of the reaction monitored by TLC analysis, in which the *R~f~* value of the starting material ketone was 0.24 (EtOAc/*n*-Hex = 1:5), the reaction mixture was concentrated under vacuum to afford light yellow oil crude product oxime. The product was used directly without further purification. To a DMF solution (1 mL) was added cyanuric chloride (182 mg, 0.987 mmol, 1.0 equiv). After being stirred at room temperature for 30 min, the solution was slowly added with the crude oxime solution in DMF (10 mL) by a cannula. The reaction mixture was allowed to be stirred under reflux overnight. Upon completion of the reaction monitored by TLC analysis, water (2.0 mL) and saturated Na~2~CO~3~ solution (1.5 mL) were slowly added into the reaction mixture. After separation of the organic layer, the aqueous layer was extracted with CH~2~Cl~2~ (10 mL ×3). The combined organic dried over Na~2~SO~4~. After removal of the solid dehydrating agent, the organic layer was concentrated under reduced pressure to give a crude product. Purification of the crude product by flash chromatography on silica gel EtOAc/*n*-Hex as the eluant gave the titled product as a light yellow solid (124 mg, 0.632 mmol, 64%, *cis*/*trans* = 1:3): mp 158--162 °C; *R~f~* = 0.14 (EtOAc/ *n*-Hex = 1:1); ^1^H NMR (400 MHz, 25 °C, CDCl~3~, δ): 0.83--1.01 (m, 1H), 1.05--1.25 (m, 3H), 1.49--1.83 (m, 7H), 1.92--2.03 (m, 5H), 2.16--2.17 (m, 0.5H), 2.73--2.87 (m, 2H), 3.65--3.74 (m, 0.5H), 5.35 (brs, 0.5H), 5.86 (brs, 0.5H). ^13^C NMR (100 MHz, 25 °C, CDCl~3~, δ): 11.4 (q), 23.4 (q), 23.8 (t), 24.27 (t), 24.33 (t), 24.7 (t), 25.37 (t), 25.44 (t), 28.8 (t), 29.1 (t), 30.3 (t), 31.9 (t), 48.7 (d), 51.0 (d), 55.6 (t), 56.2 (t), 56.3 (t), 56.6 (t), 64.1 (d), 67.3 (d), 169.5\*2 (s); EI-HRMS (*m*/*z*): \[M\]^+^ calcd for C~11~H~20~N~2~O^+^, 196.1576; found, 196.1574 (Δ = 1.0 ppm).

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b04400](https://pubs.acs.org/doi/10.1021/acsomega.9b04400?goto=supporting-info).Details of the experimental procedures for preparation of amide substrate **1a**--**1i** and tosylhydrazone derivative *trans*-**8a** and ^1^H and ^13^C NMR spectra of all compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04400/suppl_file/ao9b04400_si_001.pdf))X-ray crystallographic data of **8a** (CCDC no. 1920287) ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04400/suppl_file/ao9b04400_si_002.cif))
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